Literature DB >> 27820669

Marijuana use in acute coronary syndromes.

Eman I Draz1, Mervat M Oreby1, Eman A Elsheikh2, Lamia A Khedr2, Salwa A Atlam3.   

Abstract

BACKGROUND: Cannabis is one of the most widely used illicit substances worldwide, and it has the highest prevalence among drugs used in Egypt.
OBJECTIVES: The aims were to evaluate whether the use of cannabis is a risk factor of acute coronary heart disease in low-risk, young males and to compare the cardiac pathological changes between cannabis exposed and non-exposed ischemic patients.
METHODS: This was a cross-sectional study that was performed on 138 male patients, aged ≤ 40 years, with acute myocardial infarction who were admitted to the Cardiac Care Unit at the University Hospital. Urine samples were submitted for toxicological analysis using a homogenous enzyme immunoassay technique to determine the substance of use. The patients were divided into three groups: group 1 (n = 23), cannabis-positive only patients; group 2 (n = 28), patients positive for any other substance of use; and group 3 (n = 34), patients negative for any substance of use.
RESULTS: Smoking was prominent, whereas group 1 had no other risk factors. In groups 1 and 2, ST-segment elevation myocardial infarction (STEMI) was dominant, whereas no ST-segment elevation myocardial infarction (NSTEMI) was prominent in group 3. Ischemic resting wall motion abnormalities were presented in 47.8% of group 1 and in only 11.8% of group 3. None of group 1 had normal coronaries, whereas 14.3% of group 3 had normal coronaries. Significant changes in echocardiography and angiography were observed between group 1 and other groups.
CONCLUSION: Cannabis smoking could be a potential risk factor for the development of cardiac ischemia.

Entities:  

Keywords:  Cannabis; Egyptian; cardiac; ischemic

Mesh:

Year:  2016        PMID: 27820669     DOI: 10.1080/00952990.2016.1240800

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  4 in total

1.  A young patient with acute myocardial infarction due to bonsai treated with glycoprotein IIbIIIa inhibitor.

Authors:  Ömer Doğan; Hasan Ali Barman; Mehmet Emin Gökçe; Ayça Dönmez; Murat Kazım Ersanlı
Journal:  Anatol J Cardiol       Date:  2021-05       Impact factor: 1.596

Review 2.  Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.

Authors:  Pal Pacher; Sabine Steffens; György Haskó; Thomas H Schindler; George Kunos
Journal:  Nat Rev Cardiol       Date:  2017-09-14       Impact factor: 32.419

Review 3.  Marijuana Use in Patients With Cardiovascular Disease: JACC Review Topic of the Week.

Authors:  Ersilia M DeFilippis; Navkaranbir S Bajaj; Amitoj Singh; Rhynn Malloy; Michael M Givertz; Ron Blankstein; Deepak L Bhatt; Muthiah Vaduganathan
Journal:  J Am Coll Cardiol       Date:  2020-01-28       Impact factor: 24.094

4.  Demographic and Cardiovascular Risk Factors Associated with Drug Use in Truck Drivers in the State of São Paulo, Brazil: A Cross-Sectional Study.

Authors:  Mariana Moura Pereira; Antonio de Padua Mansur; Julio Yoshio Takada; Vilma Leyton
Journal:  Int J Environ Res Public Health       Date:  2021-05-06       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.